ING Groep NV Acquires 23,613 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

ING Groep NV increased its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 943.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 26,115 shares of the biotechnology company’s stock after purchasing an additional 23,613 shares during the quarter. ING Groep NV’s holdings in Axon Enterprise were worth $15,521,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the business. Concurrent Investment Advisors LLC raised its stake in shares of Axon Enterprise by 12.1% during the fourth quarter. Concurrent Investment Advisors LLC now owns 877 shares of the biotechnology company’s stock worth $521,000 after buying an additional 95 shares during the last quarter. Hardy Reed LLC acquired a new position in Axon Enterprise during the fourth quarter valued at approximately $220,000. Ieq Capital LLC grew its holdings in Axon Enterprise by 10.5% during the fourth quarter. Ieq Capital LLC now owns 3,149 shares of the biotechnology company’s stock valued at $1,872,000 after purchasing an additional 298 shares during the period. ICICI Prudential Asset Management Co Ltd acquired a new position in Axon Enterprise during the fourth quarter valued at approximately $590,000. Finally, Financial Management Network Inc. grew its holdings in Axon Enterprise by 10.0% during the fourth quarter. Financial Management Network Inc. now owns 550 shares of the biotechnology company’s stock valued at $331,000 after purchasing an additional 50 shares during the period. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Stock Performance

NASDAQ AXON opened at $540.00 on Friday. The firm has a market capitalization of $41.18 billion, a P/E ratio of 139.54, a price-to-earnings-growth ratio of 5.95 and a beta of 1.05. The firm’s fifty day moving average price is $622.57 and its two-hundred day moving average price is $515.53. Axon Enterprise, Inc. has a 1 year low of $260.27 and a 1 year high of $715.99. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32.

Insider Activity

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 8,711 shares of company stock valued at $5,631,561 over the last ninety days. 6.10% of the stock is currently owned by company insiders.

Analyst Ratings Changes

AXON has been the subject of a number of analyst reports. Robert W. Baird boosted their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Craig Hallum cut shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target for the company. in a report on Thursday. Northcoast Research cut shares of Axon Enterprise from a “buy” rating to a “neutral” rating in a report on Wednesday. Finally, Morgan Stanley upgraded shares of Axon Enterprise from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $500.00 to $700.00 in a report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and a consensus price target of $561.31.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.